Red flag symptoms requiring urgent medical attention include: Severe, persistent abdominal pain , particularly in the upper abdomen or epigastric region, which could indicate pancreatitis (a rare but serious adverse effect of GLP-1 therapy) Difficulty swallowing (dysphagia) or painful swallowing (odynophagia) Unintentional weight loss beyond expected therapeutic effects Persistent vomiting that prevents adequate oral intake or medication administration Right upper quadrant pain, fever, or yellowing of skin/eyes , which could indicate gallbladder disease (a known risk with weight loss on GLP-1 therapies) Symptoms of gastroparesis such as early satiety, postprandial fullness, or vomiting undigested food Call 911 or seek emergency care immediately for: Severe chest pain that could represent cardiac pathology rather than reflux Evidence of gastrointestinal bleeding , including black, tarry stools or vomiting blood or coffee-ground material If you suspect pancreatitis (persistent severe abdominal pain, sometimes radiating to the back, with or without nausea/vomiting), stop taking the GLP-1 medication immediately and seek urgent medical care, as directed in FDA prescribing information
This groundbreaking injectable medication is designed to support weight loss and enhance overall metabolic health
IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation
For detecting melanoma carcinoma physically, we can follow the ABCD rule which includes firstly, Asymmetry both sides of the wound dont look alike, Secondly, Border-irregularity edges of the skin cells suffering from melanoma are not well ordered or systematic or even, Thirdly, Color this carcinoma is an amalgam of colors, including brown, black, tan, blue or red, and at last, Diameter the diameter of the cancerous area is generally greater than 6 mm (approx
Belal et al
Dementia Trialists Collaboration JAMA 1998
